Geisinger President and CEO David Feinberg, MD, announced the program May 6 at the HLTH Conference in Las Vegas. DNA tests will initially be offered to Geisinger employees covered by Geisinger Health Plan and the first 1,000 patients who enroll in the program. Results from the genetic testing will be included in patients’ medical records.
Dr. Feinberg, who will offer the first blood sample for the clinical DNA sequencing program, hopes it will soon expand to all 3 million patients across the system’s facilities in Pennsylvania and New Jersey.
The program will expand upon Geisinger’s MyCode Community Health Initiative, which used over 200,000 participants to build a bank of DNA samples to help study the relationships between genomic data and disease.
More articles on patient engagement:
MGMA: Majority of healthcare leaders use patient wait lists for next available appointments
VCU Health is growing patient volume & retention — Here’s how
Patients are losing their patience: 7 ways healthcare consumers are demanding more
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.